【レポートの概要（一部）】
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market Definition and Scope
3.2. Parent Market Overview
3.3. Key Forces Shaping Narcolepsy Drugs Market
3.3.1. Moderate bargaining power of suppliers
3.3.2. Low bargaining power of buyers
3.3.3. Low threat of new entrants
3.3.4. Moderate threat of substitutes
3.3.5. Moderate intensity of rivalry
3.4. Pricing Analysis
3.4.1. Pricing Analysis, By Region, 2018 & 2025
3.5. Market Evolution
3.6. Value Chain Analysis
3.7. Impact of government regulations on global narcolepsy drugs market
3.8. Patent Analysis
3.8.1. By Region
3.8.2. By Applicant
3.9. Market Dynamics
3.9.1. Drivers
3.9.1.1. Increase in global prevalence of narcolepsy
3.9.1.2. Narcolepsy awareness programs and services
3.9.1.3. Presence of reimbursement policies regarding narcolepsy
3.9.2. Restraints
3.9.2.1. Adverse effects and risks related to narcolepsy drugs
3.9.2.2. Delayed diagnosis or misdiagnosis
3.9.3. Opportunity
3.9.3.1. Untapped markets in the developing countries
CHAPTER 4: NARCOLEPSY DRUGS MARKET, BY DISEASE TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Daytime Extreme Sleepiness
4.2.1. Key market trends and opportunities
4.2.2. Market size and forecast
4.2.3. Market analysis, by country
4.3. Cataplexia
4.3.1. Key market trends and opportunities
4.3.2. Market size and forecast
4.3.3. Market analysis, by country
4.4. Other Disease Type
4.4.1. Key market trends and opportunities
4.4.2. Market size and forecast
4.4.3. Market analysis, by country
CHAPTER 5: NARCOLEPSY DRUGS MARKET, BY THERAPEUTIC TYPE
5.1. Overview
5.1.1. Market size and forecast
5.2. Central Nervous System Stimulants
5.2.1. Market size and forecast
5.2.2. Market analysis, by country
5.3. Tricyclic Antidepressants
5.3.1. Market size and forecast
5.3.2. Market analysis, by country
5.4. Sodium Oxybate
5.4.1. Market size and forecast
5.4.2. Market analysis, by country
5.5. Selective Serotonin Reuptake Inhibitor
5.5.1. Market size and forecast
5.5.2. Market analysis, by country
5.6. Other Therapeutic Type
5.6.1. Market size and forecast
5.6.2. Market analysis, by country
CHAPTER 6: NARCOLEPSY DRUGS MARKET, BY REGION
6.1. Overview
6.1.1. Market size and forecast
6.2. North America
6.2.1. Key market trends and opportunities
6.2.2. North America market size and forecast, by disease type
6.2.3. North America market size and forecast, by therapeutic type
6.2.4. North America market size and forecast, by country
6.2.4.1. U.S. market size and forecast, by disease type
6.2.4.2. U.S. market size and forecast, by therapeutic type
6.2.4.3. Canada market size and forecast, by disease type
6.2.4.4. Canada market size and forecast, by therapeutic type
6.2.4.5. Mexico market size and forecast, by disease type
6.2.4.6. Mexico market size and forecast, by therapeutic type
6.3. Europe
6.3.1. Key market trends and opportunities
6.3.2. Europe market size and forecast, by disease type
6.3.3. Europe market size and forecast, by therapeutic type
6.3.4. Europe market size and forecast, by country
6.3.4.1. Germany market size and forecast, by disease type
6.3.4.2. Germany market size and forecast, by therapeutic type
6.3.4.3. France market size and forecast, by disease type
6.3.4.4. France market size and forecast, by therapeutic type
6.3.4.5. UK market size and forecast, by disease type
6.3.4.6. UK market size and forecast, by therapeutic type
6.3.4.7. Italy market size and forecast, by disease type
6.3.4.8. Italy market size and forecast, by therapeutic type
6.3.4.9. Spain market size and forecast, by disease type
6.3.4.10. Spain market size and forecast, by therapeutic type
6.3.4.11. Rest of Europe market size and forecast, by disease type
6.3.4.12. Rest of Europe market size and forecast, by therapeutic type
6.4. Asia-Pacific
6.4.1. Key market trends and opportunities
6.4.2. Asia-Pacific market size and forecast, by disease type
6.4.3. Asia-Pacific market size and forecast, by therapeutic type
6.4.4. Asia-Pacific market size and forecast, by country
6.4.4.1. Japan market size and forecast, by disease type
6.4.4.2. Japan market size and forecast, by therapeutic type
6.4.4.3. China market size and forecast, by disease type
6.4.4.4. China market size and forecast, by therapeutic type
6.4.4.5. Australia market size and forecast, by disease type
6.4.4.6. Australia market size and forecast, by therapeutic type
6.4.4.7. India market size and forecast, by disease type
6.4.4.8. India market size and forecast, by therapeutic type
6.4.4.9. South Korea market size and forecast, by disease type
6.4.4.10. South Korea market size and forecast, by therapeutic type
6.4.4.11. Rest of Asia-Pacific market size and forecast, by disease type
6.4.4.12. Rest of Asia-Pacific market size and forecast, by therapeutic type
6.5. LAMEA
6.5.1. Key market trends and opportunities
6.5.2. LAMEA market size and forecast, by disease type
6.5.3. LAMEA market size and forecast, by therapeutic type
6.5.4. LAMEA market size and forecast, by country
6.5.4.1. Brazil market size and forecast, by disease type
6.5.4.2. Brazil market size and forecast, by therapeutic type
6.5.4.3. Saudi market size and forecast, by disease type
6.5.4.4. Saudi market size and forecast, by therapeutic type
6.5.4.5. South Africa market size and forecast, by disease type
6.5.4.6. South Africa market size and forecast, by therapeutic type
6.5.4.7. Rest of LAMEA market size and forecast, by disease type
6.5.4.8. Rest of LAMEA market size and forecast, by therapeutic type
CHAPTER 7: COMPETITIVE LANDSCAPE
7.1. Introduction
7.2. Market Share Analysis of Top Players, 2018 (%)
7.3. Product Mapping of Top Players
7.4. Competitive Heatmap
CHAPTER 8: COMPANY PROFILES
8.1. ARENA PHARMACEUTICAL, INC.
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Business performance
8.2. BIOPROJET PHARMA SARL
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.3. JAZZ PHARMACEUTICAL PLC
8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Operating segments
8.3.5. Business Performance
8.3.6. Key strategic moves and developments
8.4. LIGAND PHARMACEUTICALS INCORPORATED
8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Business performance
8.5. NOVARTIS INTERNATIONAL AG
8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Business performance
8.6. SHINOGI INC.
8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Product portfolio
8.6.5. Business performance
8.7. TAKEDA PHARMACEUTICAL COMPANY
8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Business performance
8.8. TEVA PHARMACEUTICAL INDUSTRIES LTD.
8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Product portfolio
8.8.5. Business performance
【レポート販売概要】
■ タイトル：ナルコレプシー治療薬の世界市場：疾患種類別、治療種類別■ 英文：Narcolepsy Drugs Market by Disease Type (Daytime Extreme Sleepiness, Cataplexia, and Others) and Therapeutics Type (Central Nervous System Stimulants, Tricyclic Antidepressants, Sodium Oxybate, Selective Serotonin Reuptake Inhibitor, and Others): Global Opportunity Analysis and Industry Forecast, 2019–2026
■ 発行日：2019年7月
■ 調査会社：Allied Market Research
■ 商品コード：AMR9NV071
■ 調査対象地域：グローバル
- 世界のラゲッジ（手荷物）市場動向（2012-2016）TechNavio’s analysts forecast the Global Luggage market to grow at a CAGR of 8.1 percent CAGR over the period 2012-2016. One of the key factors contributing to this market growth is the increasing disposable income of the consumers. The Global Luggage market has also been witnessing a trend of an increased per capita expenditure on luggage by the consumers. However, the increasing competition from …
- アクリル酸塩コポリマーの世界市場Acrylates copolymer (CAS 25133-97-5) Market Research Report 2013 presents comprehensive data on acrylates copolymer markets globally and regionally (Europe, Asia, North America etc.) The Acrylates copolymer (CAS 25133-97-5) Market Research Report 2013 includes acrylates copolymer description, covers its application areas and related patterns. It overviews acrylates copolymer market, names acrylate …
- OTC医薬品（一般用医薬品）の世界市場World OTC pharmaceuticals – your guide to technologies, trends and revenues Where is the world OTC pharmaceutical market heading? Visiongain’s new report gives you revenue, trends, opportunities, helping you stay ahead. Our 245-page report provides 154 tables, charts, and graphs. Discover the growing trends of this industry. In particular, our new study lets you assess forecasted sales of the over …
- グローバルにおけるX線画像診断機器市場：企業動向MediPoint: Diagnostic X-Ray Imaging - Current and Future Players Summary An early diagnosis of disease is the foundation for increasing survival rates. Diagnostic X-ray imaging is the most widely used technique to achieve early detection and clinical assessment of adult and pediatric patients alike, making it a cornerstone of disease control. This report provides an analysis of the diagnostic X-ra …
- IPTV向けCDN（コンテンツデリバリネットワーク）サービスの世界市場The market leader’s offer differentiated services in the IPTV CDN market. Companies such as Alcatel-Lucent, Ericsson, AT&T, and Akamai Technologies are the top leaders in this market. Nowadays, the companies are concentrating more on the services offerings to differentiate themselves in the competition. The small and medium enterprises cannot afford in-house services for content delivery via IPTV …
- Oiltanking GmbH：石油・ガスバリューチェーン分析レポート2013Oiltanking GmbH Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "Oiltanking GmbH" Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “Oiltanking GmbH”. The report provides key information relating to oil and gas assets of the company along with its operations across the value chain. The report examines the compan …
- 疣贅性癌（Verrucous Carcinoma）：グローバル臨床試験レビュー（2014年上半期）Verrucous Carcinoma Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Verrucous Carcinoma Global Clinical Trials Review, H1, 2014" provides data on the Verrucous Carcinoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Verrucous Carcinoma. It includes an overview of the trial numbers and their recru …
- 近距離無線通信（NFC）チップの世界市場2019-2023About this market The increased penetration of smartphones is one of the key factors expected to foster the near field communication (NFC) chips market growth in the forthcoming years. NFC-enabled smartphones are often being used for peer-to-peer communication and card emulator applications. Furthermore, the increasing application of NFC chips is encouraging OEMs for integrating NFC chips in their …
- コンニャク・グルコマンナンの世界市場Konjac Glucomannan (CAS 37220-17-0) Market Research Report 2013 presents comprehensive data on Konjac glucomannan markets globally and regionally (Europe, Asia, North America etc.) The Konjac Glucomannan (CAS 37220-17-0) Market Research Report 2013 includes Konjac glucomannan description, covers its application areas and related patterns. It overviews Konjac glucomannan market, names Konjac glucom …
- 固体経口剤形（OSDF）賦形剤の世界市場About OSDF Excipients OSDF excipients are chemical compounds that are added along with API and other chemicals during the manufacture of a drug. The sole purpose of the excipients is to hold the components together in the different forms of oral dosage. Sometimes, these excipients also act as drug releasers by releasing controlled amount of the medication after ingestion of the same. The global OS …
- 世界の小売自動化市場：POS製品別、サプライチェーン別、地域別分析The global retail industry is developing at a high growth rate due to many reasons like increasing retailers’ investment in the retail sector, high demand from the customer, increasing population, and so on. Retailers require advanced and developed systems to meet current market needs; such as reducing the operational costs for retail stores, obtaining accurate results during transactions and, fas …
- 石油増進回収法（EOR）の世界市場：ガス攻法、ケミカル攻法The increase in demand of enhanced oil recovery fluids for revitalization of aging brown fields for oil & gas production is expected to be a major driver for the enhanced oil recovery market. The enhanced oil recovery market is expected to grow at a healthy growth rate of 18.2% between 2014 and 2019. Chemical EOR is the fastest growing technology within enhanced oil recovery market across the glob …
- 耐火物の世界市場：レンガ、不定形耐火物Refractories are construction materials that act as heat-resistant walls, coatings, or linings to protect units from oxidation, corrosion, erosion, and heat damage. These materials are widely used in the steel, non-ferrous metals, glass, power, cement, petrochemicals, and waste incineration industries. As a result, the refractory products market is expected to multiply and post a CAGR of close to …
- 世界の電子料金収受（ETC）システム市場分析及び予測（2013 – 2020）※当レポートは電子料金収受（ETC）システム市場の成長要因、主要イシュー、バリューチェーン、市場分析、競争環境、関連企業概要、並びにAvi、Avc、Ves商品別、技術別、応用分野別、地域別市場予測をまとめました。 Electronic Toll Collection system is mainly installed for the ease of transportation. In this system, tolls are collected with the help of electronic equipment installed on the roadside and without reducing the speed of the vehicle or stopping it. An ETC system consists of four segments named …
- 熱可塑性ポリウレタン（TPU）フィルムの世界市場2018-2022About Global Thermoplastic Polyurethane (TPU) Films TPU is a class of polyurethane plastics formed by the polyaddition reaction between a diisocyanate and one or more long- or short-chain diols. TPU films exhibit excellent toughness, flexibility, and abrasion resistance. They are used in numerous industries such as automotive, aerospace, construction, and energy. Technavio’s analysts forecast the …
